Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Harrow Inc HROW

Healthcare Biotechnology
Harrow, Inc. is an eyecare pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. It provides a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:HROW)

Harrow Provides Fourth Quarter and Year-End 2024 Unaudited Preliminary Financial Results and 2025 Revenue Guidance

Business Wire 3 days ago

Harrow Launches VEVYE® Access for All

Business Wire 3 days ago

Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®

Business Wire 9 days ago

Harrow to Report Fourth Quarter and Year-End 2024 Financial Results After Market Close on March 17, 2025

Business Wire March 3, 2025

Harrow Partners with Cencora to Launch "Harrow Cares" Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients

Business Wire January 27, 2025

Harrow Appoints Amir H. Shojaei as Chief Scientific Officer

Business Wire January 7, 2025

Harrow's ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.

Business Wire November 21, 2024

Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery

Business Wire November 20, 2024

Harrow Announces Participation in Upcoming Investor Conferences

Business Wire November 15, 2024
View More News ››

Opinion & Analysis (NDAQ:HROW)

Imprimis: Priming the Pumps for a Big 2019

Streetwise Reports November 16, 2018
View More Opinion ››

Bullboard Posts (NDAQ:HROW)

Harrow Health Inc. (NASDAQ: HROW) Sets New 52-Week High in T

BREAKING NEWS: $HROW Harrow Health Inc. (NASDAQ: HROW) Sets New 52-Week High in Thursday SessionShares of Harrow Health, Inc. (NASDAQ...
whytestocks - August 8, 2024

Harrow Health Inc. (NASDAQ: HROW) Making Surprising Moves in

Breaking News: $HROW Harrow Health Inc. (NASDAQ: HROW) Making Surprising Moves in Thursday SessionHarrow Health, Inc. (NASDAQ: HROW) has...
whytestocks - June 20, 2024

Harrow Provides TRIESENCE&#xAE; Relaunch Update

JUST IN: $HROW Harrow Provides TRIESENCE&#xAE; Relaunch UpdateSuccessful Manufacture of TRIESENCE PPQ Batch Leads to Scheduling of...
whytestocks - June 20, 2024

HARROW INC: ENVISIONING A BRIGHT FUTURE

$HROW   Excited to share an article about Harrow (NASDAQ: HROW), a leading U.S. eyecare pharmaceutical company engaged in the...
AviseAnalytics - June 20, 2024
View more Bullboard ››

Coelacanth Energy Inc.

Coelacanth Energy Inc.

Coelacanth Energy Inc. is a Montney-focused oil and natural gas exploration and development company, with lands located in ...
View More »